CISO Global, Inc. CISO
otherwise indicated or the context requires otherwise, the terms "we," "us," "our," and "our
company" refer to CISO Global, Inc., a Delaware corporation, and our wholly owned subsidiaries. Unless otherwise specified, all
dollar amounts are expressed in United States dollars.
company is a leading cybersecurity, compliance, and software firm composed of highly trained and seasoned security professionals. We
Last close
0.19
2026-10-23
Market cap
$8.5M
2026-06-30 share count
52-week range
0.16 - 1.29
Valuation FY2025 figures against the last close
P/S0.3x
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-0.42
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $26.6M | $30.8M | $33.9M | $46.5M | $15.1M | $7.2M | $1.9M | $641.6K | — |
| Cost of revenue | $19.8M | $26.2M | $31.4M | $43.8M | $13.3M | $4.4M | $936.2K | $114.7K | — |
| Gross profit | $6.8M | $4.5M | $2.6M | $2.7M | $1.8M | $2.9M | $971.8K | $526.9K | — |
| SG&A | $10.6M | $13.1M | $18.2M | $23.1M | $9.8M | $3.3M | $715.8K | $180.5K | — |
| Total operating expenses | $15.6M | $19.1M | $65.5M | $35.9M | $41.6M | $6.3M | $2.3M | $203.8K | — |
| Operating income | -$8.8M | -$14.6M | -$63.0M | -$33.1M | -$39.8M | -$3.4M | -$1.3M | $323.1K | — |
| Interest expense | $9.2M | $3.6M | $2.3M | $680.9K | $307.4K | $17.2K | $11.9K | — | — |
| Pre-tax income | -$8.1M | -$19.9M | -$65.0M | -$33.8M | -$39.1M | -$3.4M | -$1.4M | $323.1K | — |
| Income tax | — | — | $435.7K | $549 | — | — | — | — | — |
| Net income | -$8.1M | -$24.2M | -$80.2M | -$33.8M | -$39.1M | -$3.4M | -$1.4M | $323.1K | — |
| EPS, basic | -0.30 | -2.03 | -7.22 | -3.64 | -0.33 | -0.03 | -0.01 | 0.00 | — |
| EPS, diluted | -0.42 | -2.03 | -7.22 | -3.64 | -0.33 | -0.03 | -0.01 | 0.00 | — |
| Shares, diluted (wtd. avg.) | 30.6M | 12.0M | 11.1M | 9.3M | 118.9M | 111.5M | 93.1M | 70.0M | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $1.7M | $992.6K | $241.6K | $1.8M | $2.7M | $5.2M | $1.9M | $80.0K | — |
| Receivables | $1.2M | $1.8M | $2.8M | $7.9M | $4.8M | $1.0M | $532.0K | $176.0K | — |
| Inventory | — | — | $218.9K | $11.8K | $189.6K | — | — | — | — |
| Total current assets | $3.3M | $3.5M | $26.3M | $14.4M | $9.8M | $6.3M | $2.5M | $256.0K | — |
| Property, plant and equipment | $450.1K | $730.5K | $1.1M | $4.7M | $2.4M | $80.6K | $10.9K | — | — |
| Goodwill | $19.9M | $19.9M | $19.9M | $55.8M | $16.8M | $4.1M | $922.6K | — | — |
| Other intangibles | $881.1K | $1.8M | $3.5M | $8.5M | $6.5M | $2.1M | $1.1M | — | — |
| Total assets | $25.0M | $26.7M | $51.7M | $104.5M | $35.8M | $12.6M | $4.5M | $256.0K | — |
| Accounts payable | $2.7M | $6.1M | $4.8M | $5.3M | $1.7M | $328.4K | $119.3K | $14.0K | — |
| Short-term debt | $2.3M | $11.7M | $5.7M | — | $10.3M | — | — | — | — |
| Total current liabilities | $7.7M | $25.0M | $29.8M | $23.2M | $5.1M | $3.9M | $578.7K | $19.9K | — |
| Long-term debt | $3.6K | $37.3K | $7.7M | — | $4.2M | — | — | — | — |
| Total liabilities | $8.0M | $25.5M | $35.5M | $28.1M | $10.5M | $4.9M | $578.7K | $219.9K | — |
| Retained earnings | -$190.3M | -$182.3M | -$158.0M | -$77.8M | -$44.0M | -$4.9M | -$1.5M | $25.4K | — |
| Total equity | $14.8M | $1.1M | $16.1M | $76.4M | $25.3M | $7.7M | $3.9M | $36.1K | $117.8K |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$8.0M | -$3.8M | -$5.9M | -$10.7M | -$7.4M | -$1.7M | -$203.4K | $243.8K | — |
| Depreciation and amortisation | $286.1K | $322.1K | $263.8K | $736.2K | $88.0K | $13.7K | $758 | — | — |
| Stock-based compensation | $3.5M | $9.0M | $11.5M | $15.5M | $7.8M | $1.5M | — | — | — |
| Capital expenditure | $7.5K | $83.1K | $213.6K | $512.2K | — | $249 | $11.7K | — | — |
| Investing cash flow | -$7.5K | -$83.1K | -$160.2K | -$6.0M | $2.1M | $285.3K | $169.8K | — | — |
| Financing cash flow | $8.7M | $3.9M | $6.2M | $15.8M | $2.9M | $4.7M | $1.8M | -$204.8K | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001493152-26-014976.
Plot the figures US dollars
Income statement
Revenue
Cost of revenue
Gross profit
R&D
SG&A
Total operating expenses
Operating income
Interest expense
Pre-tax income
Income tax
Net income
EPS, basic
EPS, diluted
Shares, diluted (wtd. avg.)
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $641.6K | $1.9M | $7.2M | $15.1M | $46.5M | $33.9M | $30.8M | $26.6M |
| Gross profit | — | $526.9K | $971.8K | $2.9M | $1.8M | $2.7M | $2.6M | $4.5M | $6.8M |
| Net income | — | $323.1K | -$1.4M | -$3.4M | -$39.1M | -$33.8M | -$80.2M | -$24.2M | -$8.1M |
Recent filings and events
- Delisting notice The exchange has told the company it no longer meets the rules for staying listed - usually price, market cap, or filings that are late. Item 3.01
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03
- Delisting notice Item 3.01
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Officer or director change Item 5.02
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Regulation FD disclosure Item 7.01
- Director nominations Dates and mechanics for shareholders proposing directors. Item 5.08
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 8742
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| BAH | Booz Allen Hamilton Holding Corp | $9.42B | 11.4x | -6.4% |
| G | Genpact LTD | $6.86B | 13.0x | 6.6% |
| FCN | FTI CONSULTING, INC | $4.34B | 19.1x | 2.4% |
| EXPO | EXPONENT INC | $3.68B | 37.4x | 4.2% |
| HURN | Huron Consulting Group Inc. | $3.17B | 33.5x | 11.9% |
| ASTH | Astrana Health, Inc. | $2.09B | 81.4x | 56.4% |
| ICFI | ICF International, Inc. | $1.69B | 19.1x | -7.3% |
| BWMN | Bowman Consulting Group Ltd. | $742.5M | 58.7x | 14.9% |